184 related articles for article (PubMed ID: 29374731)
1. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.
Saito N; Shirai Y; Horiuchi T; Sugano H; Shiba H; Sakamoto T; Uwagawa T; Yanaga K
Anticancer Res; 2018 Feb; 38(2):987-992. PubMed ID: 29374731
[TBL] [Abstract][Full Text] [Related]
2. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following Hepatectomy.
Shen J; Wen T; Li C; Yan L; Li B; Yang J
Dig Dis; 2018; 36(4):306-313. PubMed ID: 29672305
[TBL] [Abstract][Full Text] [Related]
4. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
J Surg Oncol; 2020 Nov; 122(6):1094-1105. PubMed ID: 32634266
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
[TBL] [Abstract][Full Text] [Related]
6. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients.
El Chafic AH; Dewitt J; Leblanc JK; El Hajj II; Cote G; House MG; Sherman S; McHenry L; Pitt HA; Johnson C; Mohamadnejad M; Al-Haddad M
Endoscopy; 2013 Nov; 45(11):883-9. PubMed ID: 24165813
[TBL] [Abstract][Full Text] [Related]
8. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
Adachi T; Eguchi S; Beppu T; Ueno S; Shiraishi M; Okuda K; Yamashita Y; Kondo K; Nanashima A; Ohta M; Takami Y; Noritomi T; Kitahara K; Fujioka H
Ann Surg Oncol; 2015 Jul; 22(7):2269-78. PubMed ID: 25582737
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
11. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
[TBL] [Abstract][Full Text] [Related]
12. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
[TBL] [Abstract][Full Text] [Related]
13. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
[TBL] [Abstract][Full Text] [Related]
15. Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy.
Liu L; Wang W; Zhang Y; Long J; Zhang Z; Li Q; Chen B; Li S; Hua Y; Shen S; Peng B
Cancer Res Treat; 2018 Apr; 50(2):538-550. PubMed ID: 28602056
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
